Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: A comparative study

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 1, 2004, Pages 34-43

  Biswas, Shankha S ^a   Hughes, G Chad ^a   Scarborough, John E ^a   Domkowski, Patrick W ^a   Diodato, Luis ^a   Smith, Monica L ^a   Landolfo, Carolyn ^a   Lowe, James E ^a   Annex, Brian H ^a   Landolfo, Kevin P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR 2; DOBUTAMINE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DRUG DELIVERY SYSTEM; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEMOPERFUSION; INTRACORONARY INFUSION; INTRAMYOCARDIAL DRUG ADMINISTRATION; MALE; MYOCARDIAL HIBERNATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVASCULARIZATION; STRESS ECHOCARDIOGRAPHY; SWINE;

EID: 10744221339     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.07.003     Document Type: Article

References (35)

1. Syrnes J, Losorodo D, Vale P, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg. 1999:68:830-7.
2. Henry T. Therapeutic angiogenesis. BMJ. 1999;318:1536-40.
3. Hockel MSK, Doctrow S, Kissel T, Vaupel P. Therapeutic angiogenesis. Arch Surg. 1993:128:423-9.
4. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-4.
5. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res. 1996;56:2013-6.
6. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab. 1997;23:125-30.
7. Favard C, Ortega N, Bayard F, Plouet J. Vascular endothelial growth factor and retinal neovascularization: a new therapeutic approach for diabetic retinopathy. Diabetes Metab. 1996;22:268-73.
8. Samoto K, Ikezaki K, Ono M, et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 1995;55:1189-93.
9. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-7.
10. Boulton M, Gregor Z, McLeod D, et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol. 1997;81:228-33.
11. Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 1994;94:623-30.
12. Lopez JJ, Edelman ER, Stamler A, et al. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters. J Pharmacol Exp Ther. 1997;282:385-90.
13. Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266:H1588-95.
14. Laham RJ, Hung D, Simons M. Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery. Clin Cardiol. 1999;22:16-9.
15. Lazarous DF, Shou M, Stiber JA, et al. Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. Cardiovasc Res. 1997;36:78-85.
16. St Louis J, Hughes G, Kypson A, et al. An experimental model of chronic myocardial hibernation. Ann Thorac Surg. 2000;69:1351-7.
17. Camici P, Ferrannini E, Opie L. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis. 1989;32:217-38.
18. Cigarroa C, deFilippi C, Brickner M, Alvarez L, Wait M, Grayburn P. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 1993;88:430-6.
19. Afridi I, Kleiman N, Raizner A, Zoghbi W. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663-70.
20. DeGrado T, Hanson M, Turkington T, et al. Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography. J Nucl Cardiol. 1996;3:494-507.
21. Gambhir S, Schwaiger M, Huang S, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med. 1989;30:359-66.
22. Ng C, Holden J, DeGrado T, Raffel D, Kornguth M, Gatley SJ. Sensitivity of myocardial fluorodeoxyglucose lumped constant to glucose and insulin. Am J Physiol. 1991;260:H593-603.
23. Rahimtoola S. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation. 1996;94:3055-61.
24. Takeshita SZL, Brogi E, Kearney M, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662-70.
25. Laham RJ, Rezaee M, Post M, et al. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther. 2000;292:795-802.
26. Rajanayagam MAS, Shou M, Thirumurti V, et al. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs. JACC. 2000;35:519-26.
27. Bernotat-Danielowski S, Sharma H, Schott R, Schaper W. Generation and localization of monoclonal antibodies against fibroblast growth factor in ischaemic collateralized porcine myocardium. Cardiovasc Res. 1993;27:1220-8.
28. Inou T, Tomoioke H, Watanabe K, et al. A newly developed x-ray transparent ameroid constrictor for study on progression of gradual coronary stenosis. Basic Res Cardiol. 1980;75:537-43.
29. Shen Y-T, Vatner S. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res. 1995;76:479-88.
30. O'Konski M, Roth D, White F. Ameroid constriction of the proximal left circumflex coronary artery in wine. Am J Cardiovasc Pathol. 1986;1:69-77.
31. Roth D, Maruoka Y, Rogers J, White F, Longhurst J, Bloor C. Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium. Am J Physiol. 1987;253:H1279-288.
32. Hughes GC, Lowe JE, Kypson AP, et al. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg. 1998;66:2029-36.
33. Flugelman MY, Virmani R, Correa R, et al. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation. 1993:88:2493-500.
34. Nabel EG, Yang ZY, Plautz G, et al. Recombinant fibroblast growth factor-I promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature. 1993;362:844-6.
35. Mazue G, Bertolero F, Jacob C, Sarmientos P, Roncucci R. Preclinical and clinical studies with recombinant human basic fibroblast growth factor. Ann N Y Acad Sci. 1991;638:329-40.